Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Perform Group Surges On Access Industries Bid

Mon, 01st Sep 2014 11:22

LONDON (Alliance News) - Perform Group shares have risen by over a quarter after Access Industries Group of the US made a final cash offer to buy all of the shares in the company it does not already own for 260 pence per share, valuing Perform at GBP701.6 million.

Perform Group urged its shareholders to take no action, reiterating its confidence in its standalone strategy and growth prospects, and said it remains focussed on "delivering significant value for all shareholders".

Access said the bid - which values the remaining stake in Perform that it wants to buy at GBP410.3 million - is final and will not be increased.

US semiconductor producer Microchip Technology Inc, another US company currently looking to buy up a British peer, Monday said any offer its makes for chipmmaker CSR is likely to be solely in cash.

Microchip confirmed last Friday that it had held discussions with CSR over a potential acquisition, but said that these talks were at a "very preliminary stage".

---------
Markets: The FTSE 100 is down along with major European markets after more disappointing economic data from the eurozone, while the FTSE 250 and AIM All-Shares indexes are a touch higher.

The US markets are closed for the Labor Day holiday Monday.

FTSE 100: down 0.07% at 6,815.10
FTSE 250: up 0.2% at 15,922.82
AIM ALL-SHARE: up 0.06% at 780.56
GBP-USD: up at 1.6614
EUR-USD: down at 1.3135
GOLD: up at USD1,287.79 an ounce
OIL (Brent): up at USD103.12 a barrel
---------
Other Top UK Corporate News
----------
Newly merged Dixons Carphone confirmed via its official Twitter feed that it has signed a new long-term agreement with Vodafone Group. The agreement includes an enhanced distribution partnership, the company said, although it did not provide further details.
----------
Meanwhile, Phones 4U Finance said its subsidiary Phones 4U Ltd's UK network agreement with Vodafone Group will be terminated in February 2015. Phones 4u has been in discussions with Vodafone about a renewal of the agreement. However, it said it has become apparent that the renewal will not happen. The company expressed surprise and disappointment with Vodafone's decision.
----------
Barclays on Sunday said it has agreed to sell its retail banking, wealth and investment management, and corporate banking businesses in Spain to CaixaBank SA, as the British lender continues to put into action its plan to scale back in areas that don't meet its targeted returns. In a statement, Barclays said it is selling the Spanish businesses, which have EUR22.2 billion in assets and EUR20.5 billion of liabilities, for EUR800.0 million in cash, though the final amount is subject to adjustment based on statutory net asset value on December 31. The investment bank and Barclaycard operations are not part of the disposal, and Barclays said it is committed to the retained businesses.
----------
A high-profile fund manager has sold his entire stake in HSBC Holdings over concerns banks are facing "unquantifiable" fines from regulators, the Daily Telegraph reports. Neil Woodford, the former Invesco Perpetual fund manager who launched his Woodford Equity Income fund in June this year, said the bank remains a "conservatively managed, well-capitalised business" but said he had sold his shares due to a particular risk, namely "fine inflation" in the banking industry, the paper said. Woodford said the size of the fines being imposed on banks appears to be dictated by the company's "ability to pay" rather than the seriousness of their misconduct.
----------
A major shareholder in Tesco has sold off nearly two-thirds of its stake amid concerns the retailer has become "too risky", the Sunday Telegraph reported. David Herro, the chief executive of Harris Associates, the US investment fund, said he had cut his investment from around 3% to 1% due to the absence of a clear strategy, according to the newspaper.
----------
British Land said its mixed-use campus, Regents Place, at 30 Brock Street, London is now fully let, after The Guinness Partnership agreed to take up the remaining space on a ten-year lease. The Guinness Partnership is a charitable housing association. The letting means the completed campus of 1.5 million square foot is now fully occupied.
----------
GlaxoSmithKline faces a potential shareholder revolt from investors calling for Chairman Chris Gent to leave more quickly, the Sunday Times reported Sunday, citing a senior City source. Gent has said he will stand down next year, and is likely to be succeeded by Royal Bank of Scotland Group PLC Chairman Philip Hampton.
----------
Berkeley Group Holdings said that since the start of its current financial year, the UK housing market has reverted to normal transactions levels from the high point in 2013, while demand for its homes has continued. In an interim management statement for the period May 1 to date, the housebuilder focused on London and the South East said forward sales have been maintained at levels previously reported.
----------
AIM MOVERS
----------
Seeing Machines has risen over 25% after it signed a 15-year strategic alliance with advanced driver safety systems company Takata Corp's American subsidiary TK Holdings Inc. Seeing Machines will get revenue from a combination of minimum licence fees and royalties, and the two will look at opportunities beyond passenger cars into all forms of road vehicles. Forbidden Technologies is also doing well after it released the first alpha testing versions of its social video platform 'eva', and said customers can now apply to join the test. 'Eva' is a video editing and sharing platform based on Forbidden's FORScene cloud video platform. Crimson Tide is another big gainer after it said it has signed a "transformational" contract with a global food company which is expected to generate contracted margin revenue of GBP250,000 during the term, which will last in excess of three years. The contracted margin revenue could rise significantly above GBP250,000 depending on the number of users signed up in a worldwide rollout.
----------
Other Top Economics And General
----------
British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. The latest PMI reading was the lowest since June last year. "Sustaining the upturn is nonetheless still a positive in itself, and it should be noted that the pace of expansion remains solid and a touch above its long-run average," Markit Senior Economist Rob Dobson said. Output and new orders growth slowed even as the expansion trend was extended to one-and-a-half years. Both domestic and exports orders increased.
----------
UK mortgage approvals declined in July after recording a strong increase in June, data published by the Bank of England showed. The number of mortgages approved in July totalled 66,569 compared to 67,085 in June. It was forecast to fall to 66,000. Lending secured on dwellings increased by more-than-expected GBP2.3 billion in July versus GBP2.2 billion a month ago. Economists had forecast an increase of GBP1.9 billion. Consumer credit increased by GBP1.1 billion in July after rising GBP0.7 billion in June.
----------
Russia is seeking a peaceful resolution of the crisis in eastern Ukraine, its Foreign Minister Sergei Lavrov said, ahead of international talks in Belarus. The Russian news agency Itar-Tass quoted Lavrov as saying Russia was "promoting a political approach" to what he called "this hardest crisis and tragedy." The agency quoted him as saying Western countries should demand that the Ukrainian government stop using heavy weapons and aircraft against civilians in rebel-held areas. The West should not threaten Russia with new sanctions, he said.
----------
Russian President Vladimir Putin had on Sunday called for talks between the Ukrainian government and pro-Russian separatists fighting in the east of the country, including on the issue of "statehood". "There must be substantial negotations beginning immediately, not on technical issues but on issues regarding the political organization of society and the statehood of south-eastern Ukraine," Putin told Russian state television. The goal, he added, was to protect the interests of people in eastern Ukraine. Putin repeatedly called the embattled area "Novorossiya," or New Russia. Responding to media reactions to the broadcast, government spokesman Dmitry Peskov said that Putin was not advocating for the founding of a new state, according to Itar-Tass news agency.
----------
EU leaders on Saturday decided to "urgently" prepare a new round of sanctions against Russia, in response to Moscow's military role in neighbouring Ukraine. They accused Russia of "aggression" and called on Moscow to "immediately withdraw all its military assets and forces from Ukraine." Ukrainian President Petro Poroshenko alleged that "thousands of foreign troops and hundreds of foreign tanks" were on his country's territory.
----------
EU leaders also on Saturday appointed Polish Prime Minister Donald Tusk as the bloc's next president and selected Italian Foreign Minister Federica Mogherini to be its new top diplomat. The EU is undergoing a leadership change after elections across its 28 countries in May. Saturday's appointments end months of haggling over the two posts, currently held by Herman Van Rompuy and Catherine Ashton.
----------
China's final manufacturing purchasing managers' index was revised down in August, defying expectations of economists to confirm the flash reading, results of a survey by Markit Economics and HSBC Bank showed Monday. The final HSBC Manufacturing PMI decreased to 50.2 in August from the flash estimate of 50.3. Economists had expected no change. In July, the index was at a 17-month high of 51.7.
----------
The German economy contracted as estimated in the second quarter, a revised report from Destatis showed. Gross domestic product fell 0.2% sequentially, reversing the 0.7% growth in the first quarter. This was the first decline since the first quarter of 2013. On a yearly basis, GDP advanced by calendar adjusted 1.2%, which was slower than the 2.3% expansion seen in the first quarter.
----------
The Iraqi military retook control of the northern town of Amerli on Sunday from Islamic State militants, who had besieged it for two months. Military spokesman Qassem Atta said soldiers backed by Shiite militiamen entered Amerli, 170 kilometres north of Baghdad, after forcing the militants to end their blockade of the mainly Shiite Turkmen town.
----------
Israel announced Sunday that it plans to expropriate 400 hectares of land near Bethlehem in the Israeli-occupied West Bank. The Palestinian owners of the land have 45 days to contest the decision to Israel's Military Appeals Committee, a government spokesman said in Tel Aviv. Israeli advocacy group Peace Now said it expects Israel to use the land, located in the outpost of Gva'ot, to expand housing units in a nearby settlement.
----------
At least three people were killed and hundreds injured when Pakistani police fired rubber bullets and tear gas at protesters calling for the resignation of Prime Minister Nawaz Sharif, officials said Sunday. The violence took place during pitched battles in Islamabad between protesters led by opposition politician Imran Khan and Pakistani-Canadian cleric Tahirul Qadri, and police. More than 500 people, including children and police officers, were injured as protesters marched towards Sharif's official residence. The two-week-long protests raised fears of a military coup in a country that has been ruled by generals for half of its history, political analyst Hasan A Rizvi said.
----------
Afternoon Watchlist (all times British Summer Time)

No events scheduled
---------
Tuesday's Key UK Corporate Events

Kofax Full Year Results
Jupiter European Opportunities Trust Full Year Results
Alumasc Group Full Year Results
Johnson Service Group Half Year Results
Smart Metering Systems Half Year Results
Energy Assets Group Trading Statement
Redrow Full Year Results
Hydro International Half Year Results
Total Produce Half Year Results
Vislink Half Year Results
---------
Tuesday's Key Economic Events (all times British Summer Time)

09:30 UK PMI Construction
10:00 EU Producer Price Index
13:55 US Redbook index
14:45 US Markit Manufacturing PMI
15:00 US Construction Spending
15:00 US IBD/TIPP Economic Optimism
15:00 US ISM Manufacturing PMI

---------
Contact: +44 203 668 7440; newsroom@alliancenews.com; @AllNewsTeam

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.